Choose the format around the use case
Compare capsules, powders, liquids and chews against intended dose, ease of use, sensory requirements and packaging. The most distinctive format is useful only when it works for the product and consumer.
Separate the design idea from the evidence
A liposomal or other delivery-system label is not itself proof of improved bioavailability. Define the comparison and product-specific question before treating an absorption benefit as established.
Plan validation alongside development
Identify the formulation, stability, manufacturing and research questions early. This keeps technical exploration connected to the commercial decision rather than leaving validation until launch.
Can a delivery format guarantee better absorption?
No. Performance depends on the ingredient, formulation, comparator and study conditions. Product-specific evidence is needed to assess an enhanced-absorption claim.
How we work together
For clients under $50 million in annual revenue, new product development and portfolio management are fee-based. For clients over $50 million, these engagements can be fee-free to the client, with PCG compensated by the CDMO under agreed terms. Contract research is always separately scoped at market rates. Companies at exactly $50 million should contact PCG to confirm their engagement.
Start with your next decision.
Tell us your objective, current stage and target launch window.
Discuss your project ↗